ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Thought LeadersDr. Amy Sheng, Dr. Lurong PanTechnical Account Manager, CEOSino Biological Inc., Ainnocence In this interview, NewsMedical talks to Dr. Amy Sheng, a technical account manager at Sino ...

Explore stroke and preeclampsia treatment advancements with DiaMedica's lead drug candidate DM199 and its impact on vascular ...

Antibody engineering and production are essential tools in drug discovery, providing powerful and specific therapeutics and diagnostic/prognostic materials for various diseases. Antibodies are ...

THE STRUCTURE AND FUNCTION OF RECOMBINANT HUMANIZED TYPE III COLLAGEN AS WELL AS ITS RELATED PRODUCT approved by CHINA NMPa for COSMETICS USE (ADAPTED FROM THE AUTHORS’ PUBLICATION IN Biochemical and ...

GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been ...

The 1975 International Conference on Recombinant DNA Molecules held at the Asilomar Conference Center in California has cast a long shadow. Groundbreaking at the time, the meeting of scientists to ...

Ted Jin, founder and CEO of AuX Labs, is leading a charge in the food technology space with a mission driven by global impact ...